You are here

  • Home
  • Archive
  • Volume 9, Issue 4
  • Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy

 

Online download statistics by month:

Online download statistics by month: April 2021 to August 2025

AbstractFullPdf
Apr 2021696697456
May 2021356356225
Jun 2021267268196
Jul 202123923967
Aug 202115915958
Sep 202114114187
Oct 202117617695
Nov 202117317491
Dec 202111511749
Jan 2022949841
Feb 2022818759
Mar 2022798754
Apr 2022152166115
May 202213013470
Jun 202211912560
Jul 2022889245
Aug 2022929639
Sep 2022909661
Oct 202211211858
Nov 202213414357
Dec 2022777742
Jan 202311211638
Feb 202312212546
Mar 2023717327
Apr 2023969742
May 2023949441
Jun 2023484824
Jul 2023464629
Aug 2023687029
Sep 2023474824
Oct 2023697026
Nov 202310210334
Dec 202319119148
Jan 2024798140
Feb 2024697038
Mar 2024858564
Apr 2024727445
May 2024646530
Jun 2024706936
Jul 2024707136
Aug 2024808035
Sep 2024616153
Oct 2024899251
Nov 2024798237
Dec 202411111336
Jan 202512812831
Feb 202510510755
Mar 202511311664
Apr 202510210347
May 2025727340
Jun 2025727339
Jul 2025110
Aug 2025111
Total615962723211